γδ T cells in cancer

With the promise of T cell-based therapy for cancer finally becoming reality, this Review focuses on the less-studied γδ T cell lineage and its diverse responses to tumours. γδ T cells have well-established protective roles in cancer, largely on the basis of their potent cytotoxicity and interferon-γ production. Besides this, recent studies have revealed a series of tumour-promoting functions that are linked to interleukin-17-producing γδ T cells. Here, we integrate the current knowledge from both human and mouse studies to highlight the potential of γδ T cell modulation to improve cancer immunotherapy.

[1]  Mark M. Davis,et al.  Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. , 2008, Immunity.

[2]  L. Moretta,et al.  At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high‐risk leukemias , 2013, Journal of leukocyte biology.

[3]  Wancai Yang,et al.  γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity , 2003, The Journal of experimental medicine.

[4]  Julia M. Lewis,et al.  The Distinct Contributions of Murine T Cell Receptor (TCR)γδ+ and TCRαβ+ T Cells to Different Stages of Chemically Induced Skin Cancer , 2003, The Journal of experimental medicine.

[5]  L. Zitvogel,et al.  Harnessing γδ T cells in anticancer immunotherapy. , 2012, Trends in immunology.

[6]  A. Hayday,et al.  CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17–producing γδ T cell subsets , 2009, Nature Immunology.

[7]  P. Pereira,et al.  Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy , 2011, The Journal of experimental medicine.

[8]  A. Hayday,et al.  The integration of conventional and unconventional T cells that characterizes cell-mediated responses. , 2005, Advances in immunology.

[9]  M. Lefranc,et al.  Diversity and rearrangement of the human T cell rearranging γ genes: Nine germ-line variable genes belonging to two subgroups , 1986, Cell.

[10]  Julia M. Lewis,et al.  Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis , 2008, Nature Immunology.

[11]  B. Bloom,et al.  Natural and synthetic non-peptide antigens recognized by human γδ T cells , 1995, Nature.

[12]  E. Adams,et al.  Evolution of the V, D, and J gene segments used in the primate γδ T-cell receptor reveals a dichotomy of conservation and diversity , 2011, Proceedings of the National Academy of Sciences.

[13]  P. Vantourout,et al.  Six-of-the-best: unique contributions of γδ T cells to immunology , 2013, Nature Reviews Immunology.

[14]  J. Mehta,et al.  Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation , 2007, Bone Marrow Transplantation.

[15]  S. Tonegawa,et al.  Diversity of murine gamma genes and expression in fetal and adult T lymphocytes , 1986, Nature.

[16]  J. Jonkers,et al.  IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.

[17]  T. Schumacher,et al.  Neoantigens in cancer immunotherapy , 2015, Science.

[18]  G. De Libero,et al.  The T-Cell Response to Lipid Antigens of Mycobacterium tuberculosis , 2014, Front. Immunol..

[19]  Rbcafe The Force Awakens , 2015 .

[20]  D. Pennington,et al.  The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy. , 2015, Cancer research.

[21]  G. Laurent,et al.  What lessons can be learned from γδ T cell-based cancer immunotherapy trials? , 2012, Cellular and Molecular Immunology.

[22]  T. Mabuchi,et al.  Epidermal CCR6+ γδ T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform Dermatitis , 2011, The Journal of Immunology.

[23]  Julia M. Lewis,et al.  Regulation of Cutaneous Malignancy by γδ T Cells , 2001, Science.

[24]  S. Loi,et al.  Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. , 2011, Cancer research.

[25]  B. Silva-Santos,et al.  Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. , 2011, Blood.

[26]  C. Harly,et al.  Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells , 2014, Front. Immunol..

[27]  A. Gomes,et al.  Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. , 2010, Cancer research.

[28]  I. Eltoum,et al.  Protective Immunosurveillance and Therapeutic Antitumor Activity of γδ T Cells Demonstrated in a Mouse Model of Prostate Cancer1 , 2008, The Journal of Immunology.

[29]  R. Tampé,et al.  Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses , 2009, Proceedings of the National Academy of Sciences.

[30]  Liyun Shi,et al.  IL-17A produced by γδ T cells promotes tumor growth in hepatocellular carcinoma. , 2014, Cancer research.

[31]  A. Hayday,et al.  Skint-1 identifies a common molecular mechanism for the development of interferon-γ-secreting versus interleukin-17-secreting γδ T cells. , 2011, Immunity.

[32]  S. Lau,et al.  Phosphoantigen Presentation to TCR γδ Cells, a Conundrum Getting Less Gray Zones , 2015, Front. Immunol..

[33]  A. DeFranco,et al.  γδ intraepithelial lymphocytes are essential mediators of host–microbial homeostasis at the intestinal mucosal surface , 2011, Proceedings of the National Academy of Sciences.

[34]  A. Krueger,et al.  Development of interleukin-17-producing γδ T cells is restricted to a functional embryonic wave. , 2012, Immunity.

[35]  R. Childs,et al.  Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens , 2015, Nature Reviews Drug Discovery.

[36]  L. Lamb,et al.  Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field? , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  R. Strong,et al.  γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs. , 2012, Blood.

[38]  F. Qiu,et al.  γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. , 2014, Immunity.

[39]  T. Luedde,et al.  Chemokine receptor CCR6‐dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis , 2014, Hepatology.

[40]  H. Chi,et al.  Naturally Activated Vγ4 γδ T Cells Play a Protective Role in Tumor Immunity through Expression of Eomesodermin , 2010, The Journal of Immunology.

[41]  B. Silva-Santos,et al.  Tumor cell recognition by γδ T lymphocytes , 2013, Oncoimmunology.

[42]  N. K. Williams,et al.  Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells , 2013, Nature Immunology.

[43]  E. Elinav,et al.  Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.

[44]  G. De Libero,et al.  Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells , 2003, The Journal of experimental medicine.

[45]  S. Carding,et al.  γδ T cells: functional plasticity and heterogeneity , 2002, Nature Reviews Immunology.

[46]  B. Moser,et al.  Flexible migration program regulates γδ T-cell involvement in humoral immunity , 2003 .

[47]  E. Adams,et al.  Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells , 2015, Front. Immunol..

[48]  L. Hooper,et al.  Immune responses to the microbiota at the intestinal mucosal surface. , 2009, Immunity.

[49]  M. Wilhelm,et al.  Gamma/delta T-cell stimulation by pamidronate. , 1999, The New England journal of medicine.

[50]  A. Maitra,et al.  Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. , 2014, Cancer cell.

[51]  J. Barata,et al.  The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to gammadelta T-cell cytotoxicity. , 2010, Blood.

[52]  D. Kabelitz,et al.  Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. , 2003, Critical reviews in immunology.

[53]  E. Adams,et al.  Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. , 2012, Blood.

[54]  Hilde Cheroutre,et al.  The light and dark sides of intestinal intraepithelial lymphocytes , 2011, Nature Reviews Immunology.

[55]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[56]  Jihong Han,et al.  Regulatory Role of Vγ1 γδ T Cells in Tumor Immunity through IL-4 Production , 2011, The Journal of Immunology.

[57]  A. Macpherson,et al.  Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.

[58]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[59]  Y. Iwakura,et al.  Tumor‐infiltrating IL‐17‐producing γδ T cells support the progression of tumor by promoting angiogenesis , 2010, European journal of immunology.

[60]  A. Takeuchi,et al.  IL‐17 production by γδ T cells is important for the antitumor effect of Mycobacterium bovis bacillus Calmette‐Guérin treatment against bladder cancer , 2011, European journal of immunology.

[61]  L. Hooper,et al.  Reciprocal Interactions between Commensal Bacteria and γδ Intraepithelial Lymphocytes during Mucosal Injury1 , 2009, The Journal of Immunology.

[62]  Qunyuan Zhang,et al.  Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer , 2012, The Journal of Immunology.

[63]  M. Ferrarini,et al.  MICA Expressed by Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance Plasma Cells Costimulates Pamidronate-Activated γδ Lymphocytes , 2005 .

[64]  A. Grosso,et al.  Protective Role of the Inflammatory CCR2/CCL2 Chemokine Pathway through Recruitment of Type 1 Cytotoxic γδ T Lymphocytes to Tumor Beds , 2013, The Journal of Immunology.

[65]  N. Greenberg,et al.  NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. , 2008, Immunity.

[66]  Jamie Rossjohn,et al.  CD1d-lipid antigen recognition by the γδ TCR , 2013, Nature Immunology.

[67]  Damien Picard,et al.  Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells. , 2013, Immunity.

[68]  Marc Bonneville,et al.  Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. , 2005, Immunity.

[69]  M. Bonneville,et al.  γδ T cell effector functions: a blend of innate programming and acquired plasticity , 2010, Nature Reviews Immunology.

[70]  E. Kremmer,et al.  CCR6 and NK1.1 distinguish between IL‐17A and IFN‐γ‐producing γδ effector T cells , 2009, European journal of immunology.

[71]  S. Mattarollo,et al.  Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours , 2011, British Journal of Cancer.

[72]  D. Pennington,et al.  Murine CD27(−) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages , 2014, Proceedings of the National Academy of Sciences.

[73]  D. Pennington,et al.  Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory γδ T cell subsets , 2013, Nature Immunology.

[74]  F. Wang,et al.  Specific recruitment of γδ regulatory T cells in human breast cancer. , 2013, Cancer research.

[75]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[76]  Christian Peters,et al.  Human Gamma Delta T Regulatory Cells in Cancer: Fact or Fiction? , 2014, Front. Immunol..

[77]  S. Meraviglia,et al.  Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment , 2014, Front. Immunol..

[78]  R. Strong,et al.  Crystal structure of a γδ T-cell receptor specific for the human MHC class I homolog MICA , 2011, Proceedings of the National Academy of Sciences.

[79]  Yoshimasa Tanaka,et al.  Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells , 1995 .

[80]  T. Spies,et al.  Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB , 1999 .

[81]  Y. Carmi,et al.  Microenvironment-Derived IL-1 and IL-17 Interact in the Control of Lung Metastasis , 2011, The Journal of Immunology.

[82]  M. Todaro,et al.  Differentiation, phenotype, and function of interleukin-17-producing human Vγ9Vδ2 T cells. , 2011, Blood.

[83]  M. Smyth,et al.  Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells , 2004, The Journal of experimental medicine.

[84]  J. Gairin,et al.  In vivo major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells is regulated by γδ T and NK cells during the early steps of tumor growth , 2009 .

[85]  F. Locatelli,et al.  gd T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR- ab 1 /CD19 1 lymphocytes , 2016 .

[86]  M. Eberl,et al.  γδ T-APCs: a novel tool for immunotherapy? , 2011, Cellular and Molecular Life Sciences.

[87]  Deepak Mittal,et al.  New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape. , 2014, Current opinion in immunology.

[88]  M. Gobbi,et al.  Vδ1 T Lymphocytes from B-CLL Patients Recognize ULBP3 Expressed on Leukemic B Cells and Up-Regulated by Trans-Retinoic Acid , 2004, Cancer Research.

[89]  Carrie R Willcox,et al.  Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor , 2012, Nature Immunology.

[90]  James E. Crooks,et al.  The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. , 2014, Immunity.

[91]  M. Cheng,et al.  Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism. , 2014, Cancer research.

[92]  W. Born,et al.  gammadelta T cell subsets: a link between TCR and function? , 2010, Seminars in immunology.